Elucidating the efficacy of combination therapy and colistin resistance mechanisms in MDR/XDR Gram-negative Bacilli

Elucidating the efficacy of combination therapy and colistin resistance mechanisms in MDR/XDR Gram-negative Bacilli

Bibliographic Details
Main Authors:	Diana Abdulghani, Wael Bazzi, Antoine Abou Fayad, George F. Araj, Ghassan M. Matar
Format:	Article
Language:	English
Published:	Elsevier 2020-12-01
Series:	Journal of Infection and Public Health
Online Access:	http://www.sciencedirect.com/science/article/pii/S1876034119300425

Similar Items

Elucidating the mechanisms of colistin resistance and the efficacy of combination therapy in MDR/XDR/PDR Acinetobacter baumannii
by: A. Abou Fayad, et al.
Published: (2020-12-01)

Prevalence and molecular epidemiology of carbapenem-resistant Gram-negative bacilli and their resistance determinants in the Eastern Mediterranean Region over the last decade
by: Ahmad Sleiman, et al.
Published: (2021-06-01)

The Role of Adjunctive Therapies in Septic Shock by Gram Negative MDR/XDR Infections
by: Stefano Busani, et al.
Published: (2017-01-01)

Assessment of heavy metal and antibiotic resistance of Gram negative bacteria isolated from war-zones
by: Mouayad M. Bakleh, et al.
Published: (2020-12-01)

DECOLONIZATION OF INTESTINAL CARRIAGE OF MDR/XDR GRAM-NEGATIVE BACTERIA WITH ORAL COLISTIN IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES: RESULTS OF A RANDOMIZED CONTROLLED TRIAL
by: Igor Stoma, et al.
Published: (2018-05-01)

Resurgence of Polymyxin B for MDR/XDR Gram-Negative Infections: An Overview of Current Evidence
by: Suneel Kumar Garg, et al.
Published: (2017-01-01)

Colistin resistance in non-fermenting Gram-negative bacilli in a university hospital
by: Silvana Oliveira dos Santos, et al.
Published: (2016-11-01)

MDR & XDR Tuberculosis
by: Prahlad Kumar
Published: (2017-01-01)

Evaluating the Efficacies of Carbapenem/β-Lactamase Inhibitors Against Carbapenem-Resistant Gram-Negative Bacteria in vitro and in vivo
by: Bassam El Hafi, et al.
Published: (2019-04-01)

‘Breakpoint broth microdilution plate’ for susceptibility testing of Gram negative bacilli against colistin sulfate
by: Imran Ahmed, et al.
Published: (2020-11-01)

Chloramphenicol – A Potent Armament Against Multi-Drug Resistant (MDR) Gram Negative Bacilli?
by: Smita Sood
Published: (2016-02-01)

Colistin susceptibility among multidrug resistant Gram-negative bacilli isolated from Tertiary hospital in Egypt
by: Shimaa, A. Abdel Salam, et al.
Published: (2020-10-01)

Successful Treatment of Ventriculitis Caused by MDR/XDR Gram-Negative Bacillus Using Ceftazidime/Avibactam: Case Series and Literature Review
by: Zhou Q, et al.
Published: (2021-05-01)

Epidemiology, susceptibility, and risk factors for acquisition of MDR/XDR Gram-negative bacteria among kidney transplant recipients with urinary tract infections
by: Yuan XH, et al.
Published: (2018-05-01)

In Vitro Activity of Newer and Conventional Antimicrobial Agents, Including Fosfomycin and Colistin, against Selected Gram-Negative Bacilli in Kuwait
by: Wadha Alfouzan, et al.
Published: (2018-09-01)

Blood Stream Infections caused by Non-Fermenting Gram Negative Bacilli, Clinical Correlation, MIC for Colistin, Gene Detection
by: Angel Varghese, et al.
Published: (2020-09-01)

Transmission of MDR and XDR tuberculosis in Shanghai, China.
by: Ming Zhao, et al.
Published: (2009-01-01)

Defining multidrug resistance in Gram-negative bacilli
by: V Anil Kumar, et al.
Published: (2015-01-01)

A comparative study among different methods of detection of colistin resistant gram negative bacilli in a tertiary care hospital
by: Poonam AR, et al.
Published: (2020-04-01)

INDIVIDUAL TREATMENT OF PULMONARY MDR/XDR TUBERCULOSIS IN ADOLESCENTS
by: L. V. Pаnovа, et al.
Published: (2018-03-01)

Identification of Acinetobacter baumannii and Determination of MDR and XDR Strains
by: Noor Hussein Ahmad, et al.
Published: (2020-07-01)

Cost-effectiveness of bedaquiline in MDR and XDR tuberculosis in Italy
by: Luigi R. Codecasa, et al.
Published: (2017-01-01)

Multiple variants of phoP/Q and pmrAB TCRS conferring colistin resistance in XDR/MDR clinical isolates of Klebsiella pneumoniae in India
by: G. Yadav, et al.
Published: (2020-12-01)

The burden of MDR/XDR tuberculosis in coastal plains population of China.
by: Xiujun Yang, et al.
Published: (2015-01-01)

The rationale for using rifabutin in the treatment of MDR and XDR tuberculosis outbreaks.
by: Frederick A Sirgel, et al.
Published: (2013-01-01)

Analysing non-synonymous mutations in XDR and MDR tuberculosis drugs
by: Pallavi Surana, et al.
Published: (2019-12-01)

Characterization of molecular mechanisms of heavy metal driven antibiotics resistance in clinical and war zones isolates of Acinetobacter baumannii
by: Aya Nasser, et al.
Published: (2020-12-01)

Risk factors for MDR and XDR-TB in a tertiary referral hospital in India.
by: V Balaji, et al.
Published: (2010-01-01)

Resistance of Gram-negative bacilli isolated from patients in ICU
by: Nelya Bissenova, et al.
Published: (2016-12-01)

Development of antibiotic resistance in Gram negative bacilli: An eye opener
by: Ravinder Pal Singh, et al.
Published: (2014-01-01)

The Susceptibility Evaluation of Multiresistant Gram-Negative Bacilli to Meropenem and Imipenem
by: Nematollah Jonidi Jafari, et al.
Published: (2014-03-01)

The characterization and occurrence of clinically important gram-negative anaerobic bacilli
by: Duerden, B. I.
Published: (1979)

Comparative evaluation of the UMIC Colistine kit to assess MIC of colistin of gram-negative rods
by: Lucie Bardet, et al.
Published: (2019-03-01)

Synergistic Activity of Colistin in Combination With Resveratrol Against Colistin-Resistant Gram-Negative Pathogens
by: Antonio Cannatelli, et al.
Published: (2018-08-01)

Synergistic Activity of Colistin Combined With Auranofin Against Colistin-Resistant Gram-Negative Bacteria
by: Xiaoxuan Feng, et al.
Published: (2021-06-01)

Treatment of Infections Due to MDR Gram-Negative Bacteria
by: Matteo Bassetti, et al.
Published: (2019-04-01)

Epidemiologic characteristics of MDR/XDR tuberculosis in Montenegro, from 2005 to 2018
by: O. Bojovic, et al.
Published: (2020-12-01)

Correction: The Rationale for Using Rifabutin in the Treatment of MDR and XDR Tuberculosis Outbreaks.
by: Frederick A Sirgel, et al.
Published: (2015-01-01)

The effect of varying multidrug-resistence (MDR) definitions on rates of MDR gram-negative rods
by: Aline Wolfensberger, et al.
Published: (2019-11-01)

Circumventing colistin resistance by combining colistin and antimicrobial peptides to kill colistin-resistant and multidrug-resistant Gram-negative bacteria
by: Kaitlin S. Witherell, et al.
Published: (2020-09-01)